In December 2019, a class-action lawsuit
was filed against Merck Animal Health alleging that the company misleadingly markets Bravecto chewable tablets for dogs and topical solutions for dogs and cats as safe ways to treat and prevent fleas and ticks when, according to the complaint, the products are dangerous and may cause neurological adverse reactions. (Palmieri et al v. Intervet Inc. d/b/a Merck Animal Health
, Case No. 19-cv22024, D.N.J.)
For more of TINA.org’s coverage of pet products, click here.